Comorbidities, medications and depressive symptoms in patients with restless legs syndrome and migraine

Arq Neuropsiquiatr. 2013 Feb;71(2):87-91. doi: 10.1590/s0004-282x2013005000007. Epub 2013 Jan 11.

Abstract

Objective: The pathophysiology of migraine and restless legs syndrome (RLS) seems to involve inherited mechanism and dysfunction of the dopaminergic system. Previous articles have shown that the frequency of RLS is higher in migraine patients than in controls. We conducted a study to evaluate comorbidities, medication used and depressive symptoms that can explain the relation between migraine and RLS.

Methods: A case-control study was performed in which patients with migraine (n=72) and a control group without migraine (n=72) were interviewed. Data including RLS diagnosis, depressive symptoms, comorbidities and drugs used were evaluated.

Results: There was a significant association between migraine and RLS (p=0.01), but comorbidities such as diabetes, hypertension, anemia and drugs used did not explain this association. Depression scores, as measured by the Beck Depression Inventory, were higher in migraine patients with RLS (p =0.04).

Conclusion: No specific factors explaining the association between migraine and RLS were found. Symptoms of depression were more frequent in patients with migraine and RLS.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Brazil / epidemiology
  • Comorbidity
  • Depression / epidemiology
  • Depression / psychology
  • Epidemiologic Methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Migraine Disorders / drug therapy
  • Migraine Disorders / epidemiology*
  • Migraine Disorders / psychology
  • Personality Inventory
  • Restless Legs Syndrome / drug therapy
  • Restless Legs Syndrome / epidemiology*
  • Restless Legs Syndrome / psychology
  • Sex Distribution
  • Young Adult